Clinical Evaluation of the Analgesic Effect of Sustained Release Morphine Sulfate Microgranules in Patients with Terminal Cancer

被引：0
|
作者：
Guo-Zhu Xu
Zhi-Ji Cai
Yan-Ping Deng
Jun Hou
Guang-Ru Xie
Shu-Jun Liu
机构：
[1] Beijing Medical University,National Institute on Drug Dependence
[2] Hebei Cancer Institute,College of Oncology
[3] Tianjin Cancer Hospital,undefined
[4] Beijing Medical University,undefined
来源：
Clinical Drug Investigation | 1997年 / 14卷
关键词：
Adis International Limited; Pain Relief; Sustained Release; Numerical Rating Scale; Drug Invest;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A randomised controlled clinical trial evaluating the analgesic effect of capsules containing sustained release (SR) morphine sulfate microgranules (M-Eslon®) was conducted in 120 patients with terminal cancer and moderate or severe pain. SR morphine sulfate as a tablet formulation (MS-Contin®) was used as the control drug. Both drugs were administered orally at dosages of 20mg (lower dosage) or 30mg (higher dosage) every 12 hours for 7 days. The parameters for pain assessment were pain intensity, evaluated on a 1 to 10 numerical rating scale, and pain relief (PAR), evaluated on a 5-grade scale.
引用
收藏
页码：34 / 42
页数：8
相关论文
共 50 条
  • [21] COMPARISON OF ANALGESIC EFFECT OF INTRAMUSCULAR PENTAZOCINE AND MORPHINE IN CANCER PATIENTS
    HOUDE, RW
    BEAVER, WT
    WALLENSTEIN, SL
    PHARMACOLOGIST, 1966, 8 (02): : 207 - +
  • [22] RELATIVE BIOAVAILABILITY OF MORPHINE-SULFATE SUSTAINED-RELEASE (MS CONTIN) COMPARED TO MORPHINE-SULFATE ORAL SOLUTION IN BURN PATIENTS
    KEALEY, GP
    HERMAN, RA
    PEDERSEN, PV
    HEINLE, J
    LEWIS, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2377 - 2377
  • [23] Use of Sustained Release Oral Morphine as a Bridge in Withdrawal of Morphine in Patients on High Doses of Oral Immediate Release Morphine for Cancer Pain
    Ahmed, Arif
    Khurana, Himanshu
    Gogia, Vikas
    Mishra, Seema
    Bhatnagar, Sushma
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2010, 27 (06): : 413 - 415
  • [24] Randomised crossover comparison of the pharmacokinetic profiles of two sustained release morphine sulfate formulations in patients with cancer-related pain
    DeBernardi, M
    DeBernardi, F
    Colombo, P
    CLINICAL DRUG INVESTIGATION, 1997, 14 (Suppl 1) : 28 - 33
  • [25] Randomised Crossover Comparison of the Pharmacokinetic Profiles of Two Sustained Release Morphine Sulfate Formulations in Patients with Cancer-Related Pain
    Mario De Bernardi
    Francesca De Bernardi
    Paolo Colombo
    Clinical Drug Investigation, 1997, 14 : 28 - 33
  • [26] The analgesic effect of saffron extract in rats as compared with morphine sulfate
    Vahidi, A. R.
    Bashardost, N.
    Akhondi, H.
    PLANTA MEDICA, 2007, 73 (09) : 995 - 995
  • [27] ANALGESIC EFFECT OF TRAMADOL IN CANCER-PATIENTS WITH CHRONIC PAIN - A COMPARISON WITH PROLONGED-ACTION MORPHINE-SULFATE
    OSIPOVA, NA
    NOVIKOV, GA
    BERESNEV, VA
    LOSEVA, NA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 50 (06): : 812 - 821
  • [28] Sustained-release formulations of morphine sulfate (DepoFoam(TM) encapsulated morphine) for epidural administration
    Kohn, FR
    Willis, RC
    Dragani, JC
    Hartounian, H
    Ricci, J
    Yaksh, TL
    ANESTHESIOLOGY, 1996, 85 (3A) : A756 - A756
  • [29] COMPARISON OF THE ANALGESIC EFFECT OF INTRAMUSCULAR HEROIN AND MORPHINE IN PATIENTS WITH CANCER PAIN
    BEAVER, WT
    SCHEIN, PS
    HEXT, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 232 - 232
  • [30] A COMPARISON OF THE ANALGESIC EFFECT OF INTRAMUSCULAR HEROIN AND MORPHINE IN PATIENTS WITH CANCER PAIN
    BEAVER, WT
    SCHEIN, PS
    HEXT, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 420 - 420
12345